Pasierb Michele M, Seslar Stephen P
Division of Pediatric Cardiology,University of Washington School of Medicine,Seattle Children's Hospital,Seattle,Washington,United States of America.
Cardiol Young. 2017 Nov;27(9):1857-1860. doi: 10.1017/S1047951117001408. Epub 2017 Aug 11.
In critically ill children, multi-organ-system disease can influence the choice of antiarrhythmic medication. Intravenous therapy is often necessary. There is a scarcity of paediatric critical-care cases demonstrating the dosing, monitoring, and efficacy of intravenous sotalol. This case demonstrates the effective use of intravenous sotalol in an adolescent with renal, hepatic, and haematological dysfunctions.
在危重症儿童中,多器官系统疾病会影响抗心律失常药物的选择。静脉治疗往往是必要的。目前缺乏展示静脉注射索他洛尔的给药剂量、监测及疗效的儿科重症病例。本病例展示了静脉注射索他洛尔在一名患有肾、肝和血液系统功能障碍的青少年中的有效应用。